|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Rights Issue (Via Preemptive Right)
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Other Aspects To Be Notified
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
The transactions for the exercise of new share purchase rights, which started on 26.12.2024, regarding the increase of our Company's issued capital of 136,000,000 TL by 108,800,000 TL within the registered capital ceiling of 250,000,000 TL, by 80%, to 244,800,000 TL, all in cash, were completed on 09.01.2025. The total nominal value of the shares corresponding to our shareholders' rights to acquire new shares, which were not exercised within the allowed period, is 5,864,273.635 TL and the remaining shares will be offered for sale at the price to be established on the Primary Market at Borsa İstanbul A.Ş., not being less than the nominal value of TL 1,00, through the "Sale on Stock Exchange" method on the Primary Market of Borsa İstanbul A.Ş., through the intermediation of Tera Yatırım Menkul Değerler A.Ş., for two business days on the dates of 14.01.2025 – 15.01.2025. This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|
||||||||||||||||||||||
|